Product NDC: | 0179-0124 |
Proprietary Name: | Methylprednisolone |
Non Proprietary Name: | Methylprednisolone |
Active Ingredient(s): | 16 mg/1 & nbsp; Methylprednisolone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0124 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040189 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120912 |
Package NDC: | 0179-0124-70 |
Package Description: | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0124-70) |
NDC Code | 0179-0124-70 |
Proprietary Name | Methylprednisolone |
Package Description | 30 TABLET in 1 BOX, UNIT-DOSE (0179-0124-70) |
Product NDC | 0179-0124 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120912 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | METHYLPREDNISOLONE |
Strength Number | 16 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |